Idiopathic Pulmonary Fibrosis and Pirfenidone

European Respiratory Journal - United Kingdom
doi 10.1183/09031936.00006610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis: Nationwide Danish Results

European Clinical Respiratory Journal
2016English

Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis

Internal Medicine
Internal MedicineMedicine
2013English

Pirfenidone Should Be Prescribed for Patients With Idiopathic Pulmonary Fibrosis: Table 1

Thorax
PulmonaryRespiratory Medicine
2013English

Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis and More Advanced Lung Function Impairment

Respiratory Medicine
PulmonaryRespiratory Medicine
2019English

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2016English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Role of Pirfenidone in the Management of Pulmonary Fibrosis

Therapeutics and Clinical Risk Management
2017English

P196 Healthcare Utilisation by Patients With Idiopathic Pulmonary Fibrosis; Observations From the UK Pirfenidone Named Patient Programme

Thorax
PulmonaryRespiratory Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy